Montreal's Pharmascience Inc., Canada's 10th largest pharmaceutical company and third largest maker of generic drugs, today inaugurated a new, state-of-the-art distribution centre on 55th Avenue in Dorval, representing an investment of $4 million.
Benefits of Montreal's biopharmaceutical cluster on display with multi-faceted collaboration to develop desperately needed new treatment for acute myeloid leukemia.
Pharmascience Inc. is proud to announce that it has become the first company in the generic sector, both in Canada and around the world, to successfully accelerate the launch of the generic version of PrLyrica® . This important gain will give Canadians access to a more affordable alternative to this medication.